Table 1 Patient Characteristics.
Feature | Grade III | Grade IV |
|---|---|---|
Age | ||
<50 | 4 | 6 |
50–59 | 5 | 2 |
60–69 | 2 | 5 |
≥70 | 1 | 1 |
Gender | ||
male | 9 | 9 |
female | 3 | 5 |
KPS | ||
≤80 | 1 | 3 |
>80 | 11 | 10 |
NA | 0 | 1 |
Dose | ||
Median | 33 GyE | 34.5 GyE |
Range | 30–42 GyE | 30–42 Gye |
Status | ||
PD | 6 | 13 |
SD | 4 | 0 |
Lost to FU | 2 | 1 |
Feature | Grade III | Grade IV |
|---|---|---|
Age | ||
<50 | 4 | 6 |
50–59 | 5 | 2 |
60–69 | 2 | 5 |
≥70 | 1 | 1 |
Gender | ||
male | 9 | 9 |
female | 3 | 5 |
KPS | ||
≤80 | 1 | 3 |
>80 | 11 | 10 |
NA | 0 | 1 |
Dose | ||
Median | 33 GyE | 34.5 GyE |
Range | 30–42 GyE | 30–42 Gye |
Status | ||
PD | 6 | 13 |
SD | 4 | 0 |
Lost to FU | 2 | 1 |